Is it possible that the Cadillac Tax will be a major health spending cost ‘deflator’?
“Driven by the developmental and retail costs of specialty drugs and a less-than-robust generic drug market, pharmaceutical price increases will move into the double-digit range by 2016.” READ MORE HERE
Related posts
